臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51742417 線上人數 : 1017 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pei jer"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 1-7 / 7 (共1頁)
1
每頁顯示[10|25|50]項目

機構	日期	題名	作者
國立成功大學	2024-11	Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus	Huang;Jee-Fu;Chang;Tien-Jyun;Yeh;Ming-Lun;Shen;Feng-Chih;Tai;Chi-Ming;Chen;Jung-Fu;Huang;Yi-Hsiang;Hsu;Chih-Yao;Cheng;Pin-Nan;Lin;Ching-Ling;Hung;Chao-Hung;Chen;Ching-Chu;Lee;Mei-Hsuan;Lee;Chun-Chuan;Lin;Chih-Wen;Liu;Sung-Chen;Yang;Hwai-;I;Chien;Rong-Nan;Kuo;Chin-Sung;Peng;Cheng-Yuan;Chang;Ming-Ling;Huang;Chung-Feng;Yang;Yi-Sun;Yang;Hung-Chih;Lin;Han-Chieh;Ou;Horng-Yih;Liu;Chun-Jen;Tseng;Chin-Hsiao;Kao;Jia-Horng;Chuang;Wan-Long;Huang;Chien-Ning;Chen;Pei-Jer;Wang;Chih-Yuan;Yu;Ming-Lung
國立成功大學	2024-08-10	CVM-1118: An oral anti-vasculogenic mimicry (VM) agent in combination with nivolumab in patients with unresectable advanced hepatocellular carcinoma (HCC)-A phase IIa study.	Yen;Jui, Chia;Huang;Yi-Hsiang;Yeh;Kun-Yun;Chen;Pei-Jer;Lu;Sheng-Nan;Gutheil;John;Melink;Teresa, J.;Chen;Yen-Ling;Chen;Chun-Man;Chao;(Tiffany), Ting-Yu;Chu;Yi-Wen;Chien;Du-Shieng
國立成功大學	2024-07	Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals	Liu;Chen-Hua;Chang;Yu-Ping;Fang;Yu-Jen;Cheng;Pin-Nan;Chen;Chi-Yi;Kao;Wei-Yu;Lin;Chih-Lin;Yang;Sheng-Shun;Shih;Yu-Lueng;Peng;Cheng-Yuan;Tsai;Ming-Chang;Huang;Shang-Chin;Su;Tung-Hung;Tseng;Tai-Chung;Liu;Chun-Jen;Chen;Pei-Jer;Kao;Jia-Horng
國立成功大學	2024-06-1	CVM-1118: A potent oral anti-vasculogenic mimicry (VM) agent in combination with nivolumab in patients with unresectable advanced hepatocellular carcinoma (HCC)-A phase IIa study.	Yen;Chia-Jui;Huang;Yi-Hsiang;Yeh;Kun-Yun;Chen;Pei-Jer;Lu;Sheng-Nan;Gutheil;John;Melink;Teresa, J.;Chen;Yen-Ling;Chen;Chun-Man;Chao;Ting-Yu;Chu;Yi-Wen;Chien;Du-Shieng
國立成功大學	2024-01	Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B	Cheng;Pin-Nan;Feng;I-Cher;Chen;Jyh-Jou;Kuo;Hsing-Tao;Lee;Pei-Lun;Yu;Ming-Lung;Chiu;Yen-Cheng;Chiu;Hung-Chih;Chien;Shih-Chieh;Chen;Pei-Jer;Liu;Chun-Jen
國立成功大學	2022-12	Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial	Cheng;Pin-Nan;Liu;Chun-Jen;Chen;Chi-Yi;Tseng;Kuo-Chih;Lo;Ching-Chu;Peng;Cheng-Yuan;Lin;Chih-Lin;Chiu;Hung-Chih;Chiu;Yen-Cheng;Chen;Pei-Jer
國立成功大學	2022-05	Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral	Huang;Shang-Chin;Cheng;Pin-Nan;Liu;Chen-Hua;Yang;Hung-Chih;Su;Tung-Hung;Tseng;Tai-Chung;Chen;Pei-Jer;Kao;Jia-Horng;Liu;Chun-Jen

顯示項目 1-7 / 7 (共1頁)
1
每頁顯示[10|25|50]項目